- Home
- CRBP vs QIPT Comparison
CRBP vs QIPT Comparison
Compare CRBP & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- QIPT
- Stock Information
- Founded
- CRBP 2009
- QIPT 1993
- Country
- CRBP United States
- QIPT United States
- Employees
- CRBP N/A
- QIPT N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- QIPT
- Sector
- CRBP Health Care
- QIPT
- Exchange
- CRBP Nasdaq
- QIPT Nasdaq
- Market Cap
- CRBP 96.5M
- QIPT 92.2M
- IPO Year
- CRBP N/A
- QIPT N/A
- Fundamental
- Price
- CRBP $8.22
- QIPT $1.89
- Analyst Decision
- CRBP Strong Buy
- QIPT Buy
- Analyst Count
- CRBP 10
- QIPT 2
- Target Price
- CRBP $53.56
- QIPT $2.85
- AVG Volume (30 Days)
- CRBP 214.0K
- QIPT 556.7K
- Earning Date
- CRBP 08-05-2025
- QIPT 08-13-2025
- Dividend Yield
- CRBP N/A
- QIPT N/A
- EPS Growth
- CRBP N/A
- QIPT N/A
- EPS
- CRBP N/A
- QIPT N/A
- Revenue
- CRBP N/A
- QIPT $240,848,000.00
- Revenue This Year
- CRBP N/A
- QIPT $3.35
- Revenue Next Year
- CRBP $150.03
- QIPT $5.39
- P/E Ratio
- CRBP N/A
- QIPT N/A
- Revenue Growth
- CRBP N/A
- QIPT N/A
- 52 Week Low
- CRBP $4.64
- QIPT $1.35
- 52 Week High
- CRBP $61.90
- QIPT $4.07
- Technical
- Relative Strength Index (RSI)
- CRBP 54.23
- QIPT 49.57
- Support Level
- CRBP $7.26
- QIPT $1.72
- Resistance Level
- CRBP $7.90
- QIPT $1.82
- Average True Range (ATR)
- CRBP 0.53
- QIPT 0.09
- MACD
- CRBP -0.01
- QIPT -0.00
- Stochastic Oscillator
- CRBP 78.59
- QIPT 58.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.